AWMDMG
ARCT icon

Austin W. Marxe & David M. Greenhouse’s Arcturus Therapeutics ARCT Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.85M Sell
63,357
-22,357
-26% -$2.91M 0.93% 35
2014
Q2 		$10.4M Hold
85,714
– – 1.32% 22
2014
Q1 		$10.9M Sell
85,714
-19,270
-18% -$2.86M 1.21% 23
2013
Q4 		$13.2M Buy
104,984
+8,308
+9% +$1.04M 1.42% 21
2013
Q3 		$12.4M Hold
96,676
– – 1.53% 20
2013
Q2 		$4.64M Buy
+96,676
New +$4.74M 0.62% 58

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ARCT Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse reduced its Arcturus Therapeutics (ARCT) stake by 26% in Q3 2014, selling an estimated $2.91M and leaving 63,357 shares worth $6.85M. The position accounts for 0.93% of the portfolio, ranked #35.

Austin W. Marxe & David M. Greenhouse first reported a position in ARCT in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.2M in Q4 2013. 38 funds tracked by Wall St. Rank hold ARCT as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 63,357 shares of Arcturus Therapeutics worth $6.85M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse sold 22,357 Arcturus Therapeutics shares in Q3 2014, an estimated $2.91M.
  • Arcturus Therapeutics made up 0.93% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #35 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Arcturus Therapeutics in Q2 2013 and has held it in 6 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Arcturus Therapeutics position peaked at $13.2M in Q4 2013.
  • 38 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.